<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1990-08-01" modified="2017-12-20" version="195">
<accession>P17405</accession>
<accession>A8K8M3</accession>
<accession>E9PKS3</accession>
<accession>P17406</accession>
<accession>Q13811</accession>
<accession>Q16837</accession>
<accession>Q16841</accession>
<name>ASM_HUMAN</name>
<protein>
<recommendedName>
<fullName>Sphingomyelin phosphodiesterase</fullName>
<ecNumber evidence="15 19 21 22 36 47">3.1.4.12</ecNumber>
</recommendedName>
<alternativeName>
<fullName evidence="51">Acid sphingomyelinase</fullName>
<shortName>aSMase</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">SMPD1</name>
<name type="synonym">ASM</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="8531" last="8539">
<title>Human acid sphingomyelinase. Isolation, nucleotide sequence and expression of the full-length and alternatively spliced cDNAs.</title>
<authorList>
<person name="Schuchman E.H."/>
<person name="Suchi M."/>
<person name="Takahashi T."/>
<person name="Sandhoff K."/>
<person name="Desnick R.J."/>
</authorList>
<dbReference type="PubMed" id="1840600"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>VARIANTS ILE-322 AND ARG-506</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Biol. Chem. Hoppe-Seyler" volume="373" first="1233" last="1238">
<title>Molecular cloning of the acid sphingomyelinase of the mouse and the organization and complete nucleotide sequence of the gene.</title>
<authorList>
<person name="Newrzella D."/>
<person name="Stoffel W."/>
</authorList>
<dbReference type="PubMed" id="1292508"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ARG-506</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1992" name="Genomics" volume="12" first="197" last="205">
<title>Structural organization and complete nucleotide sequence of the gene encoding human acid sphingomyelinase (SMPD1).</title>
<authorList>
<person name="Schuchman E.H."/>
<person name="Levran O."/>
<person name="Pereira L.V."/>
<person name="Desnick R.J."/>
</authorList>
<dbReference type="PubMed" id="1740330"/>
<dbReference type="DOI" id="10.1016/0888-7543(92)90366-Z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT ALA-36</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="J. Biochem." volume="114" first="15" last="20">
<title>Cloning of a human acid sphingomyelinase cDNA with a new mutation that renders the enzyme inactive.</title>
<authorList>
<person name="Ida H."/>
<person name="Rennert O.M."/>
<person name="Eto Y."/>
<person name="Chan W.Y."/>
</authorList>
<dbReference type="PubMed" id="8407868"/>
<dbReference type="DOI" id="10.1093/oxfordjournals.jbchem.a124131"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ARG-157</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<scope>VARIANT ARG-506</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2006" name="Nature" volume="440" first="497" last="500">
<title>Human chromosome 11 DNA sequence and analysis including novel gene identification.</title>
<authorList>
<person name="Taylor T.D."/>
<person name="Noguchi H."/>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Kuroki Y."/>
<person name="Dewar K."/>
<person name="Lloyd C."/>
<person name="Itoh T."/>
<person name="Takeda T."/>
<person name="Kim D.-W."/>
<person name="She X."/>
<person name="Barlow K.F."/>
<person name="Bloom T."/>
<person name="Bruford E."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Eichler E."/>
<person name="FitzGerald M.G."/>
<person name="Jaffe D.B."/>
<person name="LaButti K."/>
<person name="Nicol R."/>
<person name="Park H.-S."/>
<person name="Seaman C."/>
<person name="Sougnez C."/>
<person name="Yang X."/>
<person name="Zimmer A.R."/>
<person name="Zody M.C."/>
<person name="Birren B.W."/>
<person name="Nusbaum C."/>
<person name="Fujiyama A."/>
<person name="Hattori M."/>
<person name="Rogers J."/>
<person name="Lander E.S."/>
<person name="Sakaki Y."/>
</authorList>
<dbReference type="PubMed" id="16554811"/>
<dbReference type="DOI" id="10.1038/nature04632"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="1989" name="EMBO J." volume="8" first="2469" last="2473">
<title>Isolation of cDNA clones encoding human acid sphingomyelinase: occurrence of alternatively processed transcripts.</title>
<authorList>
<person name="Quintern L.E."/>
<person name="Schuchman E.H."/>
<person name="Levran O."/>
<person name="Suchi M."/>
<person name="Ferlinz K."/>
<person name="Reinke H."/>
<person name="Sandhoff K."/>
<person name="Desnick R.J."/>
</authorList>
<dbReference type="PubMed" id="2555181"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 128-629</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>VARIANTS ILE-322 AND ARG-506</scope>
<source>
<tissue>Fibroblast</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="18431" last="18436">
<title>Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene.</title>
<authorList>
<person name="Schissel S.L."/>
<person name="Schuchman E.H."/>
<person name="Williams K.J."/>
<person name="Tabas I."/>
</authorList>
<dbReference type="PubMed" id="8702487"/>
<dbReference type="DOI" id="10.1074/jbc.271.31.18431"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Eur. J. Biochem." volume="243" first="511" last="517">
<title>Functional characterization of the N-glycosylation sites of human acid sphingomyelinase by site-directed mutagenesis.</title>
<authorList>
<person name="Ferlinz K."/>
<person name="Hurwitz R."/>
<person name="Moczall H."/>
<person name="Lansmann S."/>
<person name="Schuchman E.H."/>
<person name="Sandhoff K."/>
</authorList>
<dbReference type="PubMed" id="9030779"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1997.511_1a.x"/>
</citation>
<scope>GLYCOSYLATION AT ASN-86; ASN-175; ASN-335; ASN-395 AND ASN-520</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Eur. J. Biochem." volume="270" first="1076" last="1088">
<title>Human acid sphingomyelinase.</title>
<authorList>
<person name="Lansmann S."/>
<person name="Schuette C.G."/>
<person name="Bartelsen O."/>
<person name="Hoernschemeyer J."/>
<person name="Linke T."/>
<person name="Weisgerber J."/>
<person name="Sandhoff K."/>
</authorList>
<dbReference type="PubMed" id="12631268"/>
<dbReference type="DOI" id="10.1046/j.1432-1033.2003.03435.x"/>
</citation>
<scope>DISULFIDE BONDS</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="BMC Med. Genet." volume="8" first="79" last="79">
<title>Sphingomyelin phosphodiesterase-1 (SMPD1) coding variants do not contribute to low levels of high-density lipoprotein cholesterol.</title>
<authorList>
<person name="Dastani Z."/>
<person name="Ruel I.L."/>
<person name="Engert J.C."/>
<person name="Genest J. Jr."/>
<person name="Marcil M."/>
</authorList>
<dbReference type="PubMed" id="18088425"/>
<dbReference type="DOI" id="10.1186/1471-2350-8-79"/>
</citation>
<scope>POLYMORPHISM</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2016" name="Biochem. Biophys. Res. Commun." volume="479" first="496" last="501">
<title>Structural and functional analysis of the ASM p.Ala359Asp mutant that causes acid sphingomyelinase deficiency.</title>
<authorList>
<person name="Acuna M."/>
<person name="Castro-Fernandez V."/>
<person name="Latorre M."/>
<person name="Castro J."/>
<person name="Schuchman E.H."/>
<person name="Guixe V."/>
<person name="Gonzalez M."/>
<person name="Zanlungo S."/>
</authorList>
<dbReference type="PubMed" id="27659707"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2016.09.096"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT NPDB ASP-357</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2016" name="Eur. J. Hum. Genet." volume="24" first="208" last="213">
<title>Epidemiological, clinical and biochemical characterization of the p.(Ala359Asp) SMPD1 variant causing Niemann-Pick disease type B.</title>
<authorList>
<person name="Acuna M."/>
<person name="Martinez P."/>
<person name="Moraga C."/>
<person name="He X."/>
<person name="Moraga M."/>
<person name="Hunter B."/>
<person name="Nuernberg P."/>
<person name="Gutierrez R.A."/>
<person name="Gonzalez M."/>
<person name="Schuchman E.H."/>
<person name="Santos J.L."/>
<person name="Miquel J.F."/>
<person name="Mabe P."/>
<person name="Zanlungo S."/>
</authorList>
<dbReference type="PubMed" id="25920558"/>
<dbReference type="DOI" id="10.1038/ejhg.2015.89"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>VARIANT NPDB ASP-357</scope>
<scope>CHARACTERIZATION OF VARIANT NPDB ASP-357</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2016" name="J. Mol. Biol." volume="428" first="3026" last="3042">
<title>Structure of human acid sphingomyelinase reveals the role of the saposin domain in activating substrate hydrolysis.</title>
<authorList>
<person name="Xiong Z.J."/>
<person name="Huang J."/>
<person name="Poda G."/>
<person name="Pomes R."/>
<person name="Prive G.G."/>
</authorList>
<dbReference type="PubMed" id="27349982"/>
<dbReference type="DOI" id="10.1016/j.jmb.2016.06.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 47-629 OF MUTANT SER-629 IN COMPLEX WITH ZINC</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>GLYCOSYLATION AT ASN-86; ASN-175; ASN-335; ASN-395; ASN-503 AND ASN-520</scope>
<scope>DISULFIDE BONDS</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2016" name="Nat. Commun." volume="7" first="13082" last="13082">
<title>Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.</title>
<authorList>
<person name="Zhou Y.F."/>
<person name="Metcalf M.C."/>
<person name="Garman S.C."/>
<person name="Edmunds T."/>
<person name="Qiu H."/>
<person name="Wei R.R."/>
</authorList>
<dbReference type="PubMed" id="27725636"/>
<dbReference type="DOI" id="10.1038/ncomms13082"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 47-629 OF APOENZYME AND IN COMPLEX WITH PHOSPHOCHOLINE AND ZINC</scope>
<scope>COFACTOR</scope>
<scope>GLYCOSYLATION AT ASN-86; ASN-175; ASN-335; ASN-395; ASN-503 AND ASN-520</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1991" name="Biochem. Biophys. Res. Commun." volume="179" first="1187" last="1191">
<title>Molecular basis of acid sphingomyelinase deficiency in a patient with Niemann-Pick disease type A.</title>
<authorList>
<person name="Ferlinz K."/>
<person name="Hurwitz R."/>
<person name="Sandhoff K."/>
</authorList>
<dbReference type="PubMed" id="1718266"/>
<dbReference type="DOI" id="10.1016/0006-291X(91)91697-B"/>
</citation>
<scope>VARIANT NPDA SER-577</scope>
<scope>CHARACTERIZATION OF VARIANT NPDA SER-577</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="3748" last="3752">
<title>Niemann-Pick disease: a frequent missense mutation in the acid sphingomyelinase gene of Ashkenazi Jewish type A and B patients.</title>
<authorList>
<person name="Levran O."/>
<person name="Desnick R.J."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="2023926"/>
<dbReference type="DOI" id="10.1073/pnas.88.9.3748"/>
</citation>
<scope>VARIANT NPDA LEU-496</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1991" name="J. Clin. Invest." volume="88" first="806" last="810">
<title>Niemann-Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients.</title>
<authorList>
<person name="Levran O."/>
<person name="Desnick R.J."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="1885770"/>
<dbReference type="DOI" id="10.1172/JCI115380"/>
</citation>
<scope>VARIANT NPDB ARG-608 DEL</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1992" name="Blood" volume="80" first="2081" last="2087">
<title>Identification and expression of a common missense mutation (L302P) in the acid sphingomyelinase gene of Ashkenazi Jewish type A Niemann-Pick disease patients.</title>
<authorList>
<person name="Levran O."/>
<person name="Desnick R.J."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="1391960"/>
</citation>
<scope>VARIANT NPDA PRO-302</scope>
</reference>
<reference key="20">
<citation type="journal article" date="1992" name="Hum. Mutat." volume="1" first="70" last="71">
<title>Identification of a missense mutation (S436R) in the acid sphingomyelinase gene from a Japanese patient with type B Niemann-Pick disease.</title>
<authorList>
<person name="Takahashi T."/>
<person name="Desnick R.J."/>
<person name="Takada G."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="1301192"/>
<dbReference type="DOI" id="10.1002/humu.1380010111"/>
</citation>
<scope>VARIANT NPDB ARG-436</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="12552" last="12558">
<title>Identification and expression of five mutations in the human acid sphingomyelinase gene causing types A and B Niemann-Pick disease. Molecular evidence for genetic heterogeneity in the neuronopathic and non-neuronopathic forms.</title>
<authorList>
<person name="Takahashi T."/>
<person name="Suchi M."/>
<person name="Desnick R.J."/>
<person name="Takada G."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="1618760"/>
</citation>
<scope>VARIANT NPDA ILE-382</scope>
<scope>VARIANTS NPDB ARG-242 AND SER-383</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1994" name="J. Inherit. Metab. Dis." volume="17" first="93" last="103">
<title>A family with visceral course of Niemann-Pick disease, macular halo syndrome and low sphingomyelin degradation rate.</title>
<authorList>
<person name="Sperl W."/>
<person name="Bart G."/>
<person name="Vanier M.T."/>
<person name="Christomanou H."/>
<person name="Baldissera I."/>
<person name="Steichensdorf E."/>
<person name="Paschke E."/>
</authorList>
<dbReference type="PubMed" id="8051942"/>
<dbReference type="DOI" id="10.1007/BF00735404"/>
</citation>
<scope>VARIANT NPDB GLY-391</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1995" name="Hum. Mutat." volume="6" first="352" last="354">
<title>Two new mutations in the acid sphingomyelinase gene causing type A Niemann-pick disease: N389T and R441X.</title>
<authorList>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="8680412"/>
<dbReference type="DOI" id="10.1002/humu.1380060412"/>
</citation>
<scope>VARIANT NPDA THR-389</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1995" name="Tohoku J. Exp. Med." volume="177" first="117" last="123">
<title>Identification and expression of a missense mutation (Y446C) in the acid sphingomyelinase gene from a Japanese patient with type A Niemann-Pick disease.</title>
<authorList>
<person name="Takahashi T."/>
<person name="Suchi M."/>
<person name="Sato W."/>
<person name="Ten S.B."/>
<person name="Sakuragawa N."/>
<person name="Desnick R.J."/>
<person name="Schuchman E.H."/>
<person name="Takada G."/>
</authorList>
<dbReference type="PubMed" id="8693491"/>
<dbReference type="DOI" id="10.1620/tjem.177.117"/>
</citation>
<scope>VARIANT NPDA CYS-446</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="65" last="67">
<title>Identification of three novel mutations in the acid sphingomyelinase gene of Japanese patients with Niemann-Pick disease type A and B.</title>
<authorList>
<person name="Ida H."/>
<person name="Rennert O.M."/>
<person name="Maekawa K."/>
<person name="Eto Y."/>
</authorList>
<dbReference type="PubMed" id="8664904"/>
<dbReference type="DOI" id="10.1002/(SICI)1098-1004(1996)7:1&lt;65::AID-HUMU10>3.3.CO;2-8"/>
</citation>
<scope>VARIANT NPDB GLN-246</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1997" name="J. Inherit. Metab. Dis." volume="20" first="615" last="616">
<title>Two novel mutations in patients with atypical phenotypes of acid sphingomyelinase deficiency.</title>
<authorList>
<person name="Pavluu H."/>
<person name="Elleder M."/>
</authorList>
<dbReference type="PubMed" id="9266408"/>
<dbReference type="DOI" id="10.1023/A:1005387932546"/>
</citation>
<scope>VARIANTS NPDA LYS-292 AND PRO-341</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="1413" last="1419">
<title>The demographics and distribution of type B Niemann-Pick disease: novel mutations lead to new genotype/phenotype correlations.</title>
<authorList>
<person name="Simonaro C.M."/>
<person name="Desnick R.J."/>
<person name="McGovern M.M."/>
<person name="Wasserstein M.P."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="12369017"/>
<dbReference type="DOI" id="10.1086/345074"/>
</citation>
<scope>VARIANTS NPDB VAL-49; TRP-92; PRO-137; ARG-157; PRO-196; CYS-200; MET-225; CYS-228; ASP-232; SER-245; ARG-248; HIS-289; ALA-323; ARG-330; ASP-357; HIS-376; LEU-376; PRO-379; VAL-413; TYR-421; ARG-431; PRO-432; CYS-435; VAL-452; ASP-456; TRP-474; LEU-475; LEU-480; ASN-488; SER-494; CYS-496; GLN-514; VAL-515; ARG-533; PRO-549; ASN-576; HIS-600 AND PRO-600</scope>
<scope>VARIANT VAL-485</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2003" name="Ann. Hum. Genet." volume="67" first="63" last="70">
<title>Seven novel Acid sphingomyelinase gene mutations in Niemann-Pick type A and B patients.</title>
<authorList>
<person name="Sikora J."/>
<person name="Pavluu-Pereira H."/>
<person name="Elleder M."/>
<person name="Roelofs H."/>
<person name="Wevers R.A."/>
</authorList>
<dbReference type="PubMed" id="12556236"/>
<dbReference type="DOI" id="10.1046/j.1469-1809.2003.00009.x"/>
</citation>
<scope>VARIANTS NPDA ARG-248; TYR-319; SER-463; LEU-475 AND HIS-537</scope>
<scope>VARIANTS NPDB SER-371 AND ARG-608 DEL</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="105" last="105">
<title>Screening of 25 Italian patients with Niemann-Pick A reveals fourteen new mutations, one common and thirteen private, in SMPD1.</title>
<authorList>
<person name="Ricci V."/>
<person name="Stroppiano M."/>
<person name="Corsolini F."/>
<person name="Di Rocco M."/>
<person name="Parenti G."/>
<person name="Regis S."/>
<person name="Grossi S."/>
<person name="Biancheri R."/>
<person name="Mazzotti R."/>
<person name="Filocamo M."/>
</authorList>
<dbReference type="PubMed" id="15221801"/>
<dbReference type="DOI" id="10.1002/humu.9258"/>
</citation>
<scope>VARIANTS NPDA PRO-103; SER-245; LYS-246; HIS-313; PRO-450; LEU-475; LEU-496; HIS-496 AND CYS-517</scope>
<scope>VARIANT GLN-294</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2004" name="Hum. Mutat." volume="24" first="186" last="187">
<title>Acid sphingomyelinase: identification of nine novel mutations among Italian Niemann Pick type B patients and characterization of in vivo functional in-frame start codon.</title>
<authorList>
<person name="Pittis M.G."/>
<person name="Ricci V."/>
<person name="Guerci V.I."/>
<person name="Marcais C."/>
<person name="Ciana G."/>
<person name="Dardis A."/>
<person name="Gerin F."/>
<person name="Stroppiano M."/>
<person name="Vanier M.T."/>
<person name="Filocamo M."/>
<person name="Bembi B."/>
</authorList>
<dbReference type="PubMed" id="15241805"/>
<dbReference type="DOI" id="10.1002/humu.9263"/>
</citation>
<scope>VARIANTS NPDB PRO-103; PRO-225; CYS-244; THR-281; LYS-292 AND ILE-382</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2005" name="Hum. Mutat." volume="26" first="164" last="164">
<title>Functional in vitro characterization of 14 SMPD1 mutations identified in Italian patients affected by Niemann Pick type B disease.</title>
<authorList>
<person name="Dardis A."/>
<person name="Zampieri S."/>
<person name="Filocamo M."/>
<person name="Burlina A."/>
<person name="Bembi B."/>
<person name="Pittis M.G."/>
</authorList>
<dbReference type="PubMed" id="16010684"/>
<dbReference type="DOI" id="10.1002/humu.9353"/>
</citation>
<scope>VARIANTS NPDB ALA-130 AND TYR-563</scope>
<scope>CHARACTERIZATION OF VARIANTS NPDB PRO-103; ALA-130; PRO-225; CYS-244; THR-281; TYR-563; HIS-600 AND PRO-600</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2005" name="J. Inherit. Metab. Dis." volume="28" first="203" last="227">
<title>Acid sphingomyelinase deficiency. Phenotype variability with prevalence of intermediate phenotype in a series of twenty-five Czech and Slovak patients. A multi-approach study.</title>
<authorList>
<person name="Pavluu-Pereira H."/>
<person name="Asfaw B."/>
<person name="Poupctova H."/>
<person name="Ledvinova J."/>
<person name="Sikora J."/>
<person name="Vanier M.T."/>
<person name="Sandhoff K."/>
<person name="Zeman J."/>
<person name="Novotna Z."/>
<person name="Chudoba D."/>
<person name="Elleder M."/>
</authorList>
<dbReference type="PubMed" id="15877209"/>
<dbReference type="DOI" id="10.1007/s10545-005-5671-5"/>
</citation>
<scope>VARIANTS NPDA ARG-166; LEU-184; HIS-228; VAL-241; ARG-248; GLU-251; ALA-278; HIS-289; LYS-292; PRO-341; HIS-376; TRP-474; ARG-533 AND SER-577</scope>
<scope>VARIANT ARG-506</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>CHARACTERIZATION OF VARIANTS NPDA LEU-184; GLU-251; ALA-278; LYS-292; PRO-341 AND HIS-376</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2006" name="Intern. Med. J." volume="36" first="135" last="136">
<title>Clinical findings in Niemann-Pick disease type B.</title>
<authorList>
<person name="Muessig K."/>
<person name="Harzer K."/>
<person name="Mayrhofer H."/>
<person name="Kraegeloh-Mann I."/>
<person name="Haering H.-U."/>
<person name="Machicao F."/>
</authorList>
<dbReference type="PubMed" id="16472269"/>
<dbReference type="DOI" id="10.1111/j.1445-5994.2005.01013.x"/>
</citation>
<scope>VARIANTS NPDB ARG-166 AND ASN-176</scope>
<scope>VARIANT GLY-505</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Mol. Genet. Metab." volume="95" first="152" last="162">
<title>Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.</title>
<authorList>
<person name="Jones I."/>
<person name="He X."/>
<person name="Katouzian F."/>
<person name="Darroch P.I."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="18815062"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2008.08.004"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS NPDA PRO-302 AND LEU-496</scope>
<scope>CHARACTERIZATION OF VARIANTS NPDB TYR-421 AND ARG-608 DEL</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Ann. Hematol." volume="88" first="695" last="697">
<title>A novel missense mutation of the SMPD1 gene in a Taiwanese patient with type B Niemann-Pick disease.</title>
<authorList>
<person name="Lan M.Y."/>
<person name="Lin S.J."/>
<person name="Chen Y.F."/>
<person name="Peng C.H."/>
<person name="Liu Y.F."/>
</authorList>
<dbReference type="PubMed" id="19050888"/>
<dbReference type="DOI" id="10.1007/s00277-008-0648-8"/>
</citation>
<scope>VARIANTS NPDB ARG-330 AND ASP-451</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="1117" last="1122">
<title>Identification and characterization of SMPD1 mutations causing Niemann-Pick types A and B in Spanish patients.</title>
<authorList>
<person name="Rodriguez-Pascau L."/>
<person name="Gort L."/>
<person name="Schuchman E.H."/>
<person name="Vilageliu L."/>
<person name="Grinberg D."/>
<person name="Chabas A."/>
</authorList>
<dbReference type="PubMed" id="19405096"/>
<dbReference type="DOI" id="10.1002/humu.21018"/>
</citation>
<scope>VARIANTS NPDA SER-245; CYS-367; PHE-390 DEL; ARG-421; SER-467; GLU-482 AND THR-592 DEL</scope>
<scope>VARIANTS NPDB CYS-228; HIS-376; TRP-474; ALA-486 AND ARG-608 DEL</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Mol. Med." volume="16" first="316" last="321">
<title>Identification and characterization of eight novel SMPD1 mutations causing types A and B Niemann-Pick disease.</title>
<authorList>
<person name="Desnick J.P."/>
<person name="Kim J."/>
<person name="He X."/>
<person name="Wasserstein M.P."/>
<person name="Simonaro C.M."/>
<person name="Schuchman E.H."/>
</authorList>
<dbReference type="PubMed" id="20386867"/>
<dbReference type="DOI" id="10.2119/molmed.2010.00017"/>
</citation>
<scope>VARIANTS NPDA ARG-209 AND HIS-251</scope>
<scope>VARIANTS NPDB MET-312; ARG-425 AND HIS-523</scope>
<scope>CHARACTERIZATION OF VARIANTS NPDA ARG-209 AND HIS-251</scope>
<scope>CHARACTERIZATION OF VARIANTS NPDB MET-312; ARG-425 AND HIS-523</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Lancet" volume="377" first="1890" last="1890">
<title>PAS-positive macrophages--not always infection.</title>
<authorList>
<person name="Meersseman W."/>
<person name="Verschueren P."/>
<person name="Tousseyn T."/>
<person name="De Vos R."/>
<person name="Cassiman D."/>
</authorList>
<dbReference type="PubMed" id="21621718"/>
<dbReference type="DOI" id="10.1016/S0140-6736(11)60285-7"/>
</citation>
<scope>VARIANT NPDB PRO-161</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="Chin. Med. J." volume="125" first="1511" last="1512">
<title>A novel SMPD1 mutation in two Chinese sibling patients with type B Niemann-Pick disease.</title>
<authorList>
<person name="Hua R."/>
<person name="Wu H."/>
<person name="Cui Z."/>
<person name="Chen J.X."/>
<person name="Wang Z."/>
</authorList>
<dbReference type="PubMed" id="22613662"/>
</citation>
<scope>VARIANT NPDB SER-520</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2012" name="JIMD Rep." volume="3" first="125" last="129">
<title>Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing niemann-pick disease.</title>
<authorList>
<person name="Toth B."/>
<person name="Erdos M."/>
<person name="Szekely A."/>
<person name="Ritli L."/>
<person name="Bagossi P."/>
<person name="Suemegi J."/>
<person name="Marodi L."/>
</authorList>
<dbReference type="PubMed" id="23430884"/>
<dbReference type="DOI" id="10.1007/8904_2011_80"/>
</citation>
<scope>VARIANTS NPDA ASP-245 AND LEU-570</scope>
<scope>CHARACTERIZATION OF VARIANTS NPDA ASP-245 AND LEU-570</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2012" name="Mol. Genet. Metab." volume="107" first="526" last="533">
<title>Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.</title>
<authorList>
<person name="Hollak C.E."/>
<person name="de Sonnaville E.S."/>
<person name="Cassiman D."/>
<person name="Linthorst G.E."/>
<person name="Groener J.E."/>
<person name="Morava E."/>
<person name="Wevers R.A."/>
<person name="Mannens M."/>
<person name="Aerts J.M."/>
<person name="Meersseman W."/>
<person name="Akkerman E."/>
<person name="Niezen-Koning K.E."/>
<person name="Mulder M.F."/>
<person name="Visser G."/>
<person name="Wijburg F.A."/>
<person name="Lefeber D."/>
<person name="Poorthuis B.J."/>
</authorList>
<dbReference type="PubMed" id="22818240"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2012.06.015"/>
</citation>
<scope>VARIANTS NPDB HIS-89; PRO-103; PRO-161; CYS-228; SER-371; PRO-549 AND ARG-608 DEL</scope>
<scope>VARIANTS NPDA ARG-248; SER-463; LEU-475 AND HIS-537</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2013" name="Clin. Genet." volume="84" first="356" last="361">
<title>Identification of seven novel SMPD1 mutations causing Niemann-Pick disease types A and B.</title>
<authorList>
<person name="Irun P."/>
<person name="Mallen M."/>
<person name="Dominguez C."/>
<person name="Rodriguez-Sureda V."/>
<person name="Alvarez-Sala L.A."/>
<person name="Arslan N."/>
<person name="Bermejo N."/>
<person name="Guerrero C."/>
<person name="Perez de Soto I."/>
<person name="Villalon L."/>
<person name="Giraldo P."/>
<person name="Pocovi M."/>
</authorList>
<dbReference type="PubMed" id="23252888"/>
<dbReference type="DOI" id="10.1111/cge.12076"/>
</citation>
<scope>VARIANTS NPDA ARG-226 AND ARG-385</scope>
<scope>VARIANTS NPDB CYS-228; SER-245; HIS-376; TRP-474; SER-490; PHE-597 AND ARG-608 DEL</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2013" name="JIMD Rep." volume="8" first="1" last="6">
<title>The acid sphingomyelinase sequence variant p.A487V is not associated with decreased levels of enzymatic activity.</title>
<authorList>
<person name="Rhein C."/>
<person name="Naumann J."/>
<person name="Muehle C."/>
<person name="Zill P."/>
<person name="Adli M."/>
<person name="Hegerl U."/>
<person name="Hiemke C."/>
<person name="Mergl R."/>
<person name="Moeller H.J."/>
<person name="Reichel M."/>
<person name="Kornhuber J."/>
</authorList>
<dbReference type="PubMed" id="23430512"/>
<dbReference type="DOI" id="10.1007/8904_2012_147"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT NPDB ALA-323</scope>
<scope>CHARACTERIZATION OF VARIANT VAL-485</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2016" name="Am. J. Med. Genet. A" volume="170" first="2719" last="2730">
<title>Spectrum of SMPD1 mutations in Asian-Indian patients with acid sphingomyelinase (ASM)-deficient Niemann-Pick disease.</title>
<authorList>
<person name="Ranganath P."/>
<person name="Matta D."/>
<person name="Bhavani G.S."/>
<person name="Wangnekar S."/>
<person name="Jain J.M."/>
<person name="Verma I.C."/>
<person name="Kabra M."/>
<person name="Puri R.D."/>
<person name="Danda S."/>
<person name="Gupta N."/>
<person name="Girisha K.M."/>
<person name="Sankar V.H."/>
<person name="Patil S.J."/>
<person name="Ramadevi A.R."/>
<person name="Bhat M."/>
<person name="Gowrishankar K."/>
<person name="Mandal K."/>
<person name="Aggarwal S."/>
<person name="Tamhankar P.M."/>
<person name="Tilak P."/>
<person name="Phadke S.R."/>
<person name="Dalal A."/>
</authorList>
<dbReference type="PubMed" id="27338287"/>
<dbReference type="DOI" id="10.1002/ajmg.a.37817"/>
</citation>
<scope>VARIANTS ALA-36; PHE-508 AND GLY-603</scope>
<scope>VARIANTS NPDA ARG-214; CYS-228; SER-253; ARG-317; PRO-322; ARG-341; ARG-361; HIS-389; ARG-391; SER-424; ILE-492; HIS-496; ARG-533 AND HIS-600</scope>
<scope>VARIANTS NPDB PRO-103; PHE-280; ASP-318; CYS-367; SER-463; LEU-518 AND LYS-547</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2016" name="Hum. Mutat." volume="37" first="139" last="147">
<title>SMPD1 mutation update: database and comprehensive analysis of published and novel variants.</title>
<authorList>
<person name="Zampieri S."/>
<person name="Filocamo M."/>
<person name="Pianta A."/>
<person name="Lualdi S."/>
<person name="Gort L."/>
<person name="Coll M.J."/>
<person name="Sinnott R."/>
<person name="Geberhiwot T."/>
<person name="Bembi B."/>
<person name="Dardis A."/>
</authorList>
<dbReference type="PubMed" id="26499107"/>
<dbReference type="DOI" id="10.1002/humu.22923"/>
</citation>
<scope>VARIANTS NPDB ILE-256; GLN-474; ASP-575; ARG-596 AND CYS-608</scope>
<scope>VARIANT NPDA PHE-480 DEL</scope>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2015" name="Int. J. Mol. Sci." volume="16" first="13649" last="13652">
<title>Alleged detrimental mutations in the SMPD1 gene in patients with Niemann-Pick disease.</title>
<authorList>
<person name="Rhein C."/>
<person name="Muehle C."/>
<person name="Kornhuber J."/>
<person name="Reichel M."/>
</authorList>
<dbReference type="PubMed" id="26084044"/>
<dbReference type="DOI" id="10.3390/ijms160613649"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT NPDB ALA-323</scope>
<scope>CHARACTERIZATION OF VARIANTS ALA-36; VAL-485 AND ARG-506</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<comment type="function">
<text evidence="21 22 35 40 52">Converts sphingomyelin to ceramide (PubMed:1840600, PubMed:18815062, PubMed:27659707, PubMed:25920558). Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol.</text>
</comment>
<comment type="function">
<text evidence="21 52">Isoform 2 lacks residues that bind the cofactor Zn(2+) and has no enzyme activity.</text>
</comment>
<comment type="function">
<text evidence="21 52">Isoform 3 lacks residues that bind the cofactor Zn(2+) and has no enzyme activity.</text>
</comment>
<comment type="catalytic activity">
<text evidence="15 19 21 22 36 39 47">Sphingomyelin + H(2)O = N-acylsphingosine + phosphocholine.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="47">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="39 41 47">Binds 2 Zn(2+) ions per subunit (PubMed:27349982, PubMed:27725636). Zn(2+) is particularly important for enzyme activity at neutral pH (PubMed:8702487).</text>
</comment>
<comment type="subunit">
<text evidence="39">Monomer.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7095800"/>
<interactant intactId="EBI-523958">
<id>P55210</id>
<label>CASP7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="22 40">Lysosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="35 40 47">Secreted</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P17405-1</id>
<name>1</name>
<name>ASM-1</name>
<sequence type="displayed"/>
<text>Most abundant (90%).</text>
</isoform>
<isoform>
<id>P17405-2</id>
<name>2</name>
<name>ASM-2</name>
<sequence type="described" ref="VSP_000331 VSP_000332"/>
<text>Intermediate abundance (10%).</text>
</isoform>
<isoform>
<id>P17405-3</id>
<name>3</name>
<name>ASM-3</name>
<sequence type="described" ref="VSP_000333"/>
<text>Low abundance (&lt;1%).</text>
</isoform>
<isoform>
<id>P17405-4</id>
<name>4</name>
<sequence type="described" ref="VSP_046964"/>
</isoform>
</comment>
<comment type="polymorphism">
<text>A common polymorphism arises from a variable number of hexanucleotide repeat sequence within the signal peptide region.</text>
</comment>
<comment type="disease" evidence="7 11 13 15 17 19 22 25 26 27 30 31 33 37 38 45 46 49">
<disease id="DI-02053">
<name>Niemann-Pick disease A</name>
<acronym>NPDA</acronym>
<description>An early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, mental retardation, digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.</description>
<dbReference type="MIM" id="257200"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="6 7 10 14 16 17 18 22 23 24 25 27 28 29 30 31 32 35 36 37 38 40 42 44">
<disease id="DI-02054">
<name>Niemann-Pick disease B</name>
<acronym>NPDB</acronym>
<description>A late-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Clinical signs involve only visceral organs. The most constant sign is hepatosplenomegaly which can be associated with pulmonary symptoms. Patients remain free of neurologic manifestations. However, a phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B. In Niemann-Pick disease type B, onset of the first symptoms occurs in early childhood and patients can survive into adulthood.</description>
<dbReference type="MIM" id="607616"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>There are two types of sphingomyelinases: ASM (acid), and NSM (neutral).</text>
</comment>
<comment type="similarity">
<text evidence="52">Belongs to the acid sphingomyelinase family.</text>
</comment>
<comment type="caution">
<text evidence="6 13 32">Variants Gln-294 and Val-485 have been originally reported as disease-causing mutations in NPDA and NPDB (PubMed:12369017, PubMed:15221801). These variants have been reclassified as benign polymorphisms (PubMed:23430512).</text>
</comment>
<comment type="online information" name="Mendelian genes sphingomyelin phosphodiesterase 1, acid lysosomal (SMPD1)">
<link uri="http://www.lovd.nl/SMPD1"/>
<text>Leiden Open Variation Database (LOVD)</text>
</comment>
<dbReference type="EC" id="3.1.4.12" evidence="15 19 21 22 36 47"/>
<dbReference type="EMBL" id="M59916">
<property type="protein sequence ID" value="AAA58377.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M59917">
<property type="protein sequence ID" value="AAA58378.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X63600">
<property type="protein sequence ID" value="CAA45145.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M81780">
<property type="protein sequence ID" value="AAA75008.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="M81780">
<property type="protein sequence ID" value="AAA75009.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X59960">
<property type="protein sequence ID" value="CAA42584.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK292388">
<property type="protein sequence ID" value="BAF85077.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC068733">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X52678">
<property type="protein sequence ID" value="CAA36901.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X52679">
<property type="protein sequence ID" value="CAA36902.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="PIR" id="S06958">
<property type="entry name" value="S06958"/>
</dbReference>
<dbReference type="PIR" id="S27009">
<property type="entry name" value="A39825"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000534.3">
<property type="nucleotide sequence ID" value="NM_000543.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001007594.2">
<property type="nucleotide sequence ID" value="NM_001007593.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305016.1">
<property type="nucleotide sequence ID" value="NM_001318087.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001305017.1">
<property type="nucleotide sequence ID" value="NM_001318088.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.498173"/>
<dbReference type="PDB" id="5I81">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=47-629"/>
</dbReference>
<dbReference type="PDB" id="5I85">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A=47-629"/>
</dbReference>
<dbReference type="PDB" id="5I8R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.65"/>
<property type="chains" value="A/B/C=47-629"/>
</dbReference>
<dbReference type="PDB" id="5JG8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B=47-629"/>
</dbReference>
<dbReference type="PDBsum" id="5I81"/>
<dbReference type="PDBsum" id="5I85"/>
<dbReference type="PDBsum" id="5I8R"/>
<dbReference type="PDBsum" id="5JG8"/>
<dbReference type="ProteinModelPortal" id="P17405"/>
<dbReference type="SMR" id="P17405"/>
<dbReference type="BioGrid" id="112493">
<property type="interactions" value="14"/>
</dbReference>
<dbReference type="IntAct" id="P17405">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="MINT" id="MINT-3008689"/>
<dbReference type="STRING" id="9606.ENSP00000340409"/>
<dbReference type="BindingDB" id="P17405"/>
<dbReference type="ChEMBL" id="CHEMBL2760"/>
<dbReference type="DrugBank" id="DB00381">
<property type="generic name" value="Amlodipine"/>
</dbReference>
<dbReference type="DrugBank" id="DB00477">
<property type="generic name" value="Chlorpromazine"/>
</dbReference>
<dbReference type="DrugBank" id="DB01151">
<property type="generic name" value="Desipramine"/>
</dbReference>
<dbReference type="SwissLipids" id="SLP:000001748"/>
<dbReference type="iPTMnet" id="P17405"/>
<dbReference type="PhosphoSitePlus" id="P17405"/>
<dbReference type="BioMuta" id="SMPD1"/>
<dbReference type="DMDM" id="224471897"/>
<dbReference type="MaxQB" id="P17405"/>
<dbReference type="PaxDb" id="P17405"/>
<dbReference type="PeptideAtlas" id="P17405"/>
<dbReference type="PRIDE" id="P17405"/>
<dbReference type="DNASU" id="6609"/>
<dbReference type="Ensembl" id="ENST00000342245">
<property type="protein sequence ID" value="ENSP00000340409"/>
<property type="gene ID" value="ENSG00000166311"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000527275">
<property type="protein sequence ID" value="ENSP00000435350"/>
<property type="gene ID" value="ENSG00000166311"/>
</dbReference>
<dbReference type="GeneID" id="6609"/>
<dbReference type="KEGG" id="hsa:6609"/>
<dbReference type="UCSC" id="uc001mcw.4">
<molecule id="P17405-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6609"/>
<dbReference type="DisGeNET" id="6609"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000166311.9"/>
<dbReference type="GeneCards" id="SMPD1"/>
<dbReference type="GeneReviews" id="SMPD1"/>
<dbReference type="HGNC" id="HGNC:11120">
<property type="gene designation" value="SMPD1"/>
</dbReference>
<dbReference type="MalaCards" id="SMPD1"/>
<dbReference type="MIM" id="257200">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="607608">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="607616">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P17405"/>
<dbReference type="Orphanet" id="77292">
<property type="disease" value="Niemann-Pick disease type A"/>
</dbReference>
<dbReference type="Orphanet" id="77293">
<property type="disease" value="Niemann-Pick disease type B"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35969"/>
<dbReference type="eggNOG" id="KOG3770">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YYPB">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOVERGEN" id="HBG004288"/>
<dbReference type="InParanoid" id="P17405"/>
<dbReference type="KO" id="K12350"/>
<dbReference type="OrthoDB" id="EOG091G03M6"/>
<dbReference type="PhylomeDB" id="P17405"/>
<dbReference type="TreeFam" id="TF313674"/>
<dbReference type="Reactome" id="R-HSA-1660662">
<property type="pathway name" value="Glycosphingolipid metabolism"/>
</dbReference>
<dbReference type="SIGNOR" id="P17405"/>
<dbReference type="ChiTaRS" id="SMPD1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="Sphingomyelin_phosphodiesterase_1"/>
<dbReference type="GenomeRNAi" id="6609"/>
<dbReference type="PRO" id="PR:P17405"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000166311"/>
<dbReference type="CleanEx" id="HS_SMPD1"/>
<dbReference type="ExpressionAtlas" id="P17405">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P17405">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042599">
<property type="term" value="C:lamellar body"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043202">
<property type="term" value="C:lysosomal lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005764">
<property type="term" value="C:lysosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061750">
<property type="term" value="F:acid sphingomyelin phosphodiesterase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016798">
<property type="term" value="F:hydrolase activity, acting on glycosyl bonds"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004767">
<property type="term" value="F:sphingomyelin phosphodiesterase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046513">
<property type="term" value="P:ceramide biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006687">
<property type="term" value="P:glycosphingolipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043407">
<property type="term" value="P:negative regulation of MAP kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007399">
<property type="term" value="P:nervous system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035307">
<property type="term" value="P:positive regulation of protein dephosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042220">
<property type="term" value="P:response to cocaine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042493">
<property type="term" value="P:response to drug"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006685">
<property type="term" value="P:sphingomyelin catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006684">
<property type="term" value="P:sphingomyelin metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0023021">
<property type="term" value="P:termination of signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.225.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.60.21.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR004843">
<property type="entry name" value="Calcineurin-like_PHP_ApaH"/>
</dbReference>
<dbReference type="InterPro" id="IPR029052">
<property type="entry name" value="Metallo-depent_PP-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR011001">
<property type="entry name" value="Saposin-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR008139">
<property type="entry name" value="SaposinB_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011160">
<property type="entry name" value="Sphingomy_PDE"/>
</dbReference>
<dbReference type="Pfam" id="PF00149">
<property type="entry name" value="Metallophos"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000948">
<property type="entry name" value="Sphingomy_PDE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00741">
<property type="entry name" value="SapB"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47862">
<property type="entry name" value="SSF47862"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56300">
<property type="entry name" value="SSF56300"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50015">
<property type="entry name" value="SAP_B"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0326">Glycosidase</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0458">Lysosome</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-1054">Niemann-Pick disease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="signal peptide">
<location>
<begin position="1"/>
<end position="46"/>
</location>
</feature>
<feature type="chain" description="Sphingomyelin phosphodiesterase" id="PRO_0000002323">
<location>
<begin position="47"/>
<end position="629"/>
</location>
</feature>
<feature type="domain" description="Saposin B-type" evidence="5">
<location>
<begin position="85"/>
<end position="169"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="1 2 3 4 39">
<location>
<position position="206"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; via tele nitrogen" evidence="1 2 3 4 39">
<location>
<position position="208"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1" evidence="1 2 3 4 39">
<location>
<position position="278"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 2 3 4 39">
<location>
<position position="278"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2" evidence="1 2 3 4 39">
<location>
<position position="318"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2; via tele nitrogen" evidence="1 2 3 4 39">
<location>
<position position="425"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 2; via pros nitrogen" evidence="1 2 3 4 39">
<location>
<position position="457"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc 1; via tele nitrogen" evidence="1 2 3 4 39">
<location>
<position position="459"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 5 39 48">
<location>
<position position="86"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 5 39 48">
<location>
<position position="175"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 3 4 5 39 48">
<location>
<position position="335"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 5 39 48">
<location>
<position position="395"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 39">
<location>
<position position="503"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1 2 3 4 5 39 48">
<location>
<position position="520"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 39">
<location>
<begin position="89"/>
<end position="165"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 39">
<location>
<begin position="92"/>
<end position="157"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 8 39">
<location>
<begin position="120"/>
<end position="131"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 8 39">
<location>
<begin position="221"/>
<end position="226"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 8 39">
<location>
<begin position="227"/>
<end position="250"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 8 39">
<location>
<begin position="385"/>
<end position="431"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 8 39">
<location>
<begin position="584"/>
<end position="588"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4 5 8 39">
<location>
<begin position="594"/>
<end position="607"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_046964" evidence="50">
<location>
<position position="104"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_000333" evidence="52">
<location>
<begin position="363"/>
<end position="418"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_000331" evidence="52">
<original>IGGFYALSPYPG</original>
<variation>YLSSVETQEGKR</variation>
<location>
<begin position="363"/>
<end position="374"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_000332" evidence="52">
<location>
<begin position="375"/>
<end position="418"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; does not affect enzymatic activity; dbSNP:rs1050228." id="VAR_038191" evidence="20 36 38">
<original>V</original>
<variation>A</variation>
<location>
<position position="36"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; unknown pathological significance." id="VAR_060870" evidence="6">
<original>D</original>
<variation>V</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; requires 2 nucleotide substitutions." id="VAR_075322" evidence="30">
<original>C</original>
<variation>H</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060871" evidence="6">
<original>C</original>
<variation>W</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA and NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains very low enzyme activity." id="VAR_060872" evidence="13 14 16 30 38">
<original>L</original>
<variation>P</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains 13% residual enzyme activity." id="VAR_060873" evidence="16">
<original>V</original>
<variation>A</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060874" evidence="6">
<original>L</original>
<variation>P</variation>
<location>
<position position="137"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_011387" evidence="6 43">
<original>C</original>
<variation>R</variation>
<location>
<position position="157"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_075323" evidence="30">
<original>L</original>
<variation>P</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; also in patients with an intermediate form." id="VAR_060875" evidence="15 18">
<original>G</original>
<variation>R</variation>
<location>
<position position="166"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060876" evidence="18">
<original>I</original>
<variation>N</variation>
<location>
<position position="176"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060877" evidence="15">
<original>P</original>
<variation>L</variation>
<location>
<position position="184"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060878" evidence="6">
<original>A</original>
<variation>P</variation>
<location>
<position position="196"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060879" evidence="6">
<original>R</original>
<variation>C</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; results in less than 0.5% of wild-type activity." id="VAR_068435" evidence="27">
<original>W</original>
<variation>R</variation>
<location>
<position position="209"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_077311" evidence="38">
<original>L</original>
<variation>R</variation>
<location>
<position position="214"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060880" evidence="6">
<original>L</original>
<variation>M</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains no enzyme activity." id="VAR_060881" evidence="14 16">
<original>L</original>
<variation>P</variation>
<location>
<position position="225"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_075324" evidence="31">
<original>C</original>
<variation>R</variation>
<location>
<position position="226"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB and NPDA; some patients have a NPDA/NPDB intermediate phenotype." id="VAR_060882" evidence="6 25 30 31 38">
<original>R</original>
<variation>C</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060883" evidence="15">
<original>R</original>
<variation>H</variation>
<location>
<position position="228"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060884" evidence="6">
<original>G</original>
<variation>D</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060885" evidence="15">
<original>A</original>
<variation>V</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_005058" evidence="17">
<original>G</original>
<variation>R</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains no enzyme activity." id="VAR_060886" evidence="14 16">
<original>W</original>
<variation>C</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; severe decrease in activity; the mutant is highly unstable." id="VAR_075325" evidence="33">
<original>G</original>
<variation>D</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA and NPDB." id="VAR_060887" evidence="6 13 25 31">
<original>G</original>
<variation>S</variation>
<location>
<position position="245"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060888" evidence="13">
<original>E</original>
<variation>K</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; 30% residual activity." id="VAR_005059" evidence="44">
<original>E</original>
<variation>Q</variation>
<location>
<position position="246"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA and NPDB; also found in patients with an intermediate form." id="VAR_015287" evidence="6 7 15 30">
<original>S</original>
<variation>R</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060889" evidence="15">
<original>D</original>
<variation>E</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; results in loss of activity." id="VAR_068436" evidence="27">
<original>D</original>
<variation>H</variation>
<location>
<position position="251"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_077312" evidence="38">
<original>P</original>
<variation>S</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_075326" evidence="37">
<original>T</original>
<variation>I</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060890" evidence="15">
<original>D</original>
<variation>A</variation>
<location>
<position position="278"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; requires 2 nucleotide substitutions." id="VAR_077313" evidence="38">
<original>P</original>
<variation>F</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains no enzyme activity." id="VAR_060891" evidence="14 16">
<original>A</original>
<variation>T</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; also in patients with an intermediate form; unknown pathological significance." id="VAR_060892" evidence="6 15">
<original>R</original>
<variation>H</variation>
<location>
<position position="289"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060893" evidence="14 15 49">
<original>Q</original>
<variation>K</variation>
<location>
<position position="292"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35824453." id="VAR_060894" evidence="13">
<original>R</original>
<variation>Q</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; in 23% of NPDA Ashkenazi Jewish patients; abolishes enzyme activity." id="VAR_005060" evidence="11 22">
<original>L</original>
<variation>P</variation>
<location>
<position position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; results in 20% of wild-type activity." id="VAR_068437" evidence="27">
<original>V</original>
<variation>M</variation>
<location>
<position position="312"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060895" evidence="13">
<original>Y</original>
<variation>H</variation>
<location>
<position position="313"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12575136." id="VAR_054642">
<original>V</original>
<variation>E</variation>
<location>
<position position="316"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_077314" evidence="38">
<original>G</original>
<variation>R</variation>
<location>
<position position="317"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; unknown pathological significance." id="VAR_077315" evidence="38">
<original>N</original>
<variation>D</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_015288" evidence="7 30">
<original>H</original>
<variation>Y</variation>
<location>
<position position="319"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1050233." id="VAR_054643" evidence="21 34 36">
<original>T</original>
<variation>I</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; unknown pathological significance." id="VAR_077316" evidence="38">
<original>T</original>
<variation>P</variation>
<location>
<position position="322"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; results in 1-4% of wild type activity." id="VAR_060896" evidence="6 32 36">
<original>P</original>
<variation>A</variation>
<location>
<position position="323"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060897" evidence="6 24">
<original>P</original>
<variation>R</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; strongly reduces enzyme activity; intermediate form with clinical features of both Niemann-Pick disease types A and B." id="VAR_060898" evidence="15 49">
<original>L</original>
<variation>P</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_077317" evidence="38">
<original>L</original>
<variation>R</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; sphingomyelinase activity is decreased to 4% of wild-type activity; no effect on protein abundance; no effect on protein localization to lysosome; no effect on protein localization to extracellular space." id="VAR_060899" evidence="6 35 40">
<original>A</original>
<variation>D</variation>
<location>
<position position="357"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; unknown pathological significance." id="VAR_077318" evidence="38">
<original>L</original>
<variation>R</variation>
<location>
<position position="361"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060900" evidence="25 38">
<original>Y</original>
<variation>C</variation>
<location>
<position position="367"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_015289" evidence="7 30">
<original>P</original>
<variation>S</variation>
<location>
<position position="371"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; reduces enzyme activity; some patients have a NPDA/NPDB intermediate phenotype." id="VAR_060901" evidence="6 15 25 31">
<original>R</original>
<variation>H</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060902" evidence="6">
<original>R</original>
<variation>L</variation>
<location>
<position position="376"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060903" evidence="6">
<original>S</original>
<variation>P</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA and NPDB." id="VAR_005061" evidence="14 17">
<original>M</original>
<variation>I</variation>
<location>
<position position="382"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_005062" evidence="17">
<original>N</original>
<variation>S</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_075327" evidence="31">
<original>C</original>
<variation>R</variation>
<location>
<position position="385"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_077319" evidence="38">
<original>N</original>
<variation>H</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_005063" evidence="45">
<original>N</original>
<variation>T</variation>
<location>
<position position="389"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060904" evidence="25">
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; low sphingomyelin degradation rates." id="VAR_005064" evidence="42">
<original>W</original>
<variation>G</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; intermediate form." id="VAR_077320" evidence="38">
<original>W</original>
<variation>R</variation>
<location>
<position position="391"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060905" evidence="6">
<original>A</original>
<variation>V</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060906" evidence="25">
<original>H</original>
<variation>R</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; abolishes enzyme activity." id="VAR_015290" evidence="6 22">
<original>H</original>
<variation>Y</variation>
<location>
<position position="421"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_077321" evidence="38">
<original>G</original>
<variation>S</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; results in loss of activity; the patient also carries mutation H-228 that has sufficient activity to account for the Niemann-Pick disease type B phenotype." id="VAR_068438" evidence="27">
<original>H</original>
<variation>R</variation>
<location>
<position position="425"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060907" evidence="6">
<original>C</original>
<variation>R</variation>
<location>
<position position="431"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060908" evidence="6">
<original>L</original>
<variation>P</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060909" evidence="6">
<original>W</original>
<variation>C</variation>
<location>
<position position="435"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_005065" evidence="10">
<original>S</original>
<variation>R</variation>
<location>
<position position="436"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_011388" evidence="46">
<original>Y</original>
<variation>C</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060910" evidence="13">
<original>L</original>
<variation>P</variation>
<location>
<position position="450"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_068439" evidence="24">
<original>A</original>
<variation>D</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060911" evidence="6">
<original>A</original>
<variation>V</variation>
<location>
<position position="452"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060912" evidence="6">
<original>G</original>
<variation>D</variation>
<location>
<position position="456"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_015291" evidence="7 38">
<original>F</original>
<variation>S</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060913" evidence="25">
<original>Y</original>
<variation>S</variation>
<location>
<position position="467"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; unknown pathological significance." id="VAR_075328" evidence="37">
<original>R</original>
<variation>Q</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; some patients have a NPDA/NPDB intermediate phenotype." id="VAR_060914" evidence="6 15 25 31">
<original>R</original>
<variation>W</variation>
<location>
<position position="474"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA and NPDB." id="VAR_015292" evidence="6 7 13 30">
<original>P</original>
<variation>L</variation>
<location>
<position position="475"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060915" evidence="6">
<original>F</original>
<variation>L</variation>
<location>
<position position="480"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; unknown pathological significance." id="VAR_075329" evidence="37">
<location>
<position position="480"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060916" evidence="25">
<original>A</original>
<variation>E</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; does not affect enzymatic activity; dbSNP:rs141641266." id="VAR_060917" evidence="6 32 36">
<original>A</original>
<variation>V</variation>
<location>
<position position="485"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060918" evidence="25">
<original>T</original>
<variation>A</variation>
<location>
<position position="486"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060919" evidence="6">
<original>Y</original>
<variation>N</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_075330" evidence="31">
<original>G</original>
<variation>S</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; intermediate form." id="VAR_077322" evidence="38">
<original>N</original>
<variation>I</variation>
<location>
<position position="492"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060920" evidence="6">
<original>G</original>
<variation>S</variation>
<location>
<position position="494"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060921" evidence="6">
<original>R</original>
<variation>C</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060922" evidence="13 38">
<original>R</original>
<variation>H</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; in 32% of NPDA Ashkenazi Jewish patients; nearly abolishes enzyme activity." id="VAR_005066" evidence="13 22 26">
<original>R</original>
<variation>L</variation>
<location>
<position position="496"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_060923" evidence="18">
<original>S</original>
<variation>G</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; does not affect enzymatic activity; dbSNP:rs1050239." id="VAR_054644" evidence="9 12 15 21 34">
<original>G</original>
<variation>R</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_077323" evidence="38">
<original>S</original>
<variation>F</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060924" evidence="6">
<original>H</original>
<variation>Q</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060925" evidence="6">
<original>E</original>
<variation>V</variation>
<location>
<position position="515"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060926" evidence="13">
<original>Y</original>
<variation>C</variation>
<location>
<position position="517"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_077324" evidence="38">
<original>I</original>
<variation>L</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_068440" evidence="29">
<original>N</original>
<variation>S</variation>
<location>
<position position="520"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; results in 64% of wild-type activity." id="VAR_068441" evidence="27">
<original>Q</original>
<variation>H</variation>
<location>
<position position="523"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB and NPDA; also in patients with an intermediate form." id="VAR_060927" evidence="6 15 38">
<original>W</original>
<variation>R</variation>
<location>
<position position="533"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_015293" evidence="7 30">
<original>Y</original>
<variation>H</variation>
<location>
<position position="537"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_077325" evidence="38">
<original>N</original>
<variation>K</variation>
<location>
<position position="547"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060928" evidence="6 30">
<original>L</original>
<variation>P</variation>
<location>
<position position="549"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains 6.8% residual enzyme activity." id="VAR_060929" evidence="16">
<original>D</original>
<variation>Y</variation>
<location>
<position position="563"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; results in decreased activity; decreased stability." id="VAR_075331" evidence="33">
<original>F</original>
<variation>L</variation>
<location>
<position position="570"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; unknown pathological significance." id="VAR_075332" evidence="37">
<original>H</original>
<variation>D</variation>
<location>
<position position="575"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_060930" evidence="6">
<original>K</original>
<variation>N</variation>
<location>
<position position="576"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA; impairs enzyme activity; also in patients with an intermediate form." id="VAR_005067" evidence="15 19">
<original>G</original>
<variation>S</variation>
<location>
<position position="577"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDA." id="VAR_060931" evidence="25">
<location>
<position position="592"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB." id="VAR_075333" evidence="37">
<original>Q</original>
<variation>R</variation>
<location>
<position position="596"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; unknown pathological significance." id="VAR_075334" evidence="31">
<original>L</original>
<variation>F</variation>
<location>
<position position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB and NPDA; expresses protein level comparable to wild-type SMPD1 expressing cells; retains about 10% residual enzyme activity." id="VAR_060932" evidence="6 16 38">
<original>R</original>
<variation>H</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; expresses protein level comparable to wild-type SMPD1 expressing cells; retains very low enzyme activity." id="VAR_060933" evidence="6 16">
<original>R</original>
<variation>P</variation>
<location>
<position position="600"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_077326" evidence="38">
<original>S</original>
<variation>G</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; unknown pathological significance." id="VAR_075335" evidence="37">
<original>R</original>
<variation>C</variation>
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence variant" description="In NPDB; nearly abolishes enzyme activity; some patients have a NPDA/NPDB intermediate phenotype." id="VAR_005068" evidence="7 22 23 25 30 31">
<location>
<position position="608"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; CAA42584." ref="4" evidence="52">
<location>
<begin position="35"/>
<end position="36"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAF85077." ref="5" evidence="52">
<original>G</original>
<variation>D</variation>
<location>
<position position="268"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="88"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="106"/>
<end position="122"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="128"/>
<end position="148"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="149"/>
<end position="151"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="153"/>
<end position="161"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="163"/>
<end position="165"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="198"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="222"/>
<end position="225"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="247"/>
<end position="249"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="254"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="265"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="271"/>
<end position="275"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="289"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="312"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="320"/>
<end position="323"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="334"/>
<end position="338"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="339"/>
<end position="348"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="350"/>
<end position="352"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="355"/>
<end position="364"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="367"/>
<end position="372"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="375"/>
<end position="379"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="382"/>
<end position="385"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="390"/>
<end position="393"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="399"/>
<end position="401"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="402"/>
<end position="416"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="419"/>
<end position="423"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="428"/>
<end position="430"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="433"/>
<end position="445"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="446"/>
<end position="449"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="450"/>
<end position="455"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="462"/>
<end position="467"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="469"/>
<end position="471"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="474"/>
<end position="481"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="488"/>
<end position="490"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="494"/>
<end position="501"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="511"/>
<end position="518"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="521"/>
<end position="524"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="534"/>
<end position="538"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="539"/>
<end position="543"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="550"/>
<end position="561"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="564"/>
<end position="574"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="575"/>
<end position="577"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="586"/>
<end position="597"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="600"/>
<end position="602"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="604"/>
<end position="607"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="608"/>
<end position="610"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I81"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I85"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I8R"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JG8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00415"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12369017"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12556236"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12631268"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1292508"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1301192"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1391960"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15221801"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15241805"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15877209"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16010684"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1618760"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16472269"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1718266"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1740330"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1840600"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18815062"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1885770"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19050888"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19405096"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2023926"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20386867"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21621718"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22613662"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22818240"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23252888"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23430512"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23430884"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2555181"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25920558"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26084044"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26499107"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27338287"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27349982"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27659707"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27725636"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8051942"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8407868"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8664904"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8680412"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8693491"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8702487"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9030779"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9266408"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="27349982"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<sequence length="629" mass="69752" checksum="C9888CB8359C42AC" modified="2009-03-03" version="4" precursor="true">
MPRYGASLRQSCPRSGREQGQDGTAGAPGLLWMGLVLALALALALALSDSRVLWAPAEAH
PLSPQGHPARLHRIVPRLRDVFGWGNLTCPICKGLFTAINLGLKKEPNVARVGSVAIKLC
NLLKIAPPAVCQSIVHLFEDDMVEVWRRSVLSPSEACGLLLGSTCGHWDIFSSWNISLPT
VPKPPPKPPSPPAPGAPVSRILFLTDLHWDHDYLEGTDPDCADPLCCRRGSGLPPASRPG
AGYWGEYSKCDLPLRTLESLLSGLGPAGPFDMVYWTGDIPAHDVWHQTRQDQLRALTTVT
ALVRKFLGPVPVYPAVGNHESTPVNSFPPPFIEGNHSSRWLYEAMAKAWEPWLPAEALRT
LRIGGFYALSPYPGLRLISLNMNFCSRENFWLLINSTDPAGQLQWLVGELQAAEDRGDKV
HIIGHIPPGHCLKSWSWNYYRIVARYENTLAAQFFGHTHVDEFEVFYDEETLSRPLAVAF
LAPSATTYIGLNPGYRVYQIDGNYSGSSHVVLDHETYILNLTQANIPGAIPHWQLLYRAR
ETYGLPNTLPTAWHNLVYRMRGDMQLFQTFWFLYHKGHPPSEPCGTPCRLATLCAQLSAR
ADSPALCRHLMPDGSLPEAQSLWPRPLFC
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>